polatuzumabrituximabAxi-celdarunaviraxicabtagene ciloleucelemtricitabinefludarabinetenofovirnon-Hodgkin lymphomaonco-hematological malignancies+1 more
…y with axicabtagene ciloleucel (axi-cel). Bridging therapy with polatuzumab plus rituximab, followed by Axi-cel infusion after a standard l…